▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
▁of 0.109375
▁post 7.203125
- 0.67333984375
tre 2.498046875
at 0.0246734619140625
ment 0.00739288330078125
▁de 1.8291015625
pression 0.10272216796875
. 1.7509765625
<0x0A> 2.30078125
There 4.9140625
▁is 1.0654296875
▁currently 4.5859375
▁a 1.1552734375
▁severe 4.91015625
▁lack 3.27734375
▁of 0.0261077880859375
▁information 2.103515625
▁about 1.4169921875
▁the 0.4765625
▁effects 2.91796875
▁of 0.0743408203125
▁op 1.8154296875
i 3.99609375
ates 0.11663818359375
. 3.830078125
▁They 4.8984375
▁manage 8.859375
▁pain 3.560546875
▁successfully 5.82421875
, 1.029296875
▁but 0.324462890625
▁the 2.630859375
▁past 9.5390625
▁few 2.517578125
▁dec 0.79052734375
ades 7.331371307373047e-05
▁indicated 9.671875
▁the 2.0390625
▁growing 4.6640625
▁concern 3.58203125
▁regarding 2.783203125
▁op 3.623046875
iate 0.689453125
▁ab 1.53515625
use 0.00832366943359375
▁in 3.4296875
▁forms 10.5234375
▁of 0.401611328125
▁over 3.30078125
d 0.350341796875
ose 0.1868896484375
▁and 0.69873046875
▁add 1.1181640625
iction 0.02740478515625
. 0.2044677734375
▁vit 17.484375
amin 0.5087890625
_ 7.44140625
A 4.75
▁more 8.578125
▁manage 9.5234375
able 0.1771240234375
▁and 2.412109375
▁sa 2.685546875
fer 0.00035762786865234375
▁alternative 2.833984375
▁might 6.7578125
▁be 0.40771484375
▁medical 2.865234375
▁mar 0.1787109375
iju 0.005352020263671875
ana 0.001514434814453125
. 1.3642578125
▁However 3.228515625
, 0.0107421875
▁the 1.572265625
▁legal 4.35546875
▁status 1.1220703125
▁and 2.794921875
▁novel 9.2421875
ty 0.61083984375
▁of 0.205078125
▁this 1.6435546875
▁drug 2.091796875
▁do 4.984375
▁not 0.09674072265625
▁allow 1.140625
▁finding 8.609375
▁a 2.40234375
▁large 4.2265625
▁number 1.3408203125
▁of 0.005023956298828125
▁studies 1.423828125
▁on 1.4970703125
▁its 1.0078125
▁effect 2.08984375
iveness 0.394775390625
. 1.0751953125
▁Specifically 8.2265625
, 0.11016845703125
▁it 2.662109375
▁concerns 4.95703125
▁the 0.6005859375
▁emot 7.359375
ional 0.016448974609375
▁condition 5.34765625
▁of 0.36767578125
▁patients 0.666015625
▁experien 6.359375
cing 6.151199340820312e-05
▁chron 1.2490234375
ic 0.0029144287109375
▁pain 0.100341796875
. 0.71142578125
▁This 3.208984375
▁research 2.994140625
▁paper 6.23046875
▁a 2.263671875
ims 0.0004944801330566406
▁to 0.08526611328125
▁analyze 2.9921875
▁levels 9.4140625
▁of 0.03509521484375
▁de 0.59765625
pression 0.036956787109375
▁and 0.268310546875
▁anx 0.0433349609375
iety 0.0013399124145507812
▁among 0.7822265625
▁people 3.296875
▁receiving 0.93505859375
▁ther 7.8515625
apy 0.31005859375
▁by 5.23828125
▁comparing 8.09375
▁the 0.96484375
▁effects 2.17578125
▁of 0.0281982421875
▁ph 2.44140625
arma 0.046356201171875
ce 0.0014514923095703125
ut 8.189678192138672e-05
ical 0.0038280487060546875
▁op 0.328857421875
io 0.167724609375
ids 0.061431884765625
▁and 0.2568359375
▁MM 1.591796875
. 1.0439453125
<0x0A> 1.158203125
The 1.3740234375
▁study 2.14453125
▁was 2.197265625
▁conducted 0.73974609375
▁in 1.55859375
▁the 1.4140625
▁form 2.1171875
▁of 0.0083160400390625
▁collection 9.921875
▁and 1.66796875
▁analysis 0.69482421875
▁of 0.042022705078125
▁statistical 4.11328125
▁data 0.1282958984375
. 0.974609375
▁Part 5.0
icip 0.0675048828125
ants 0.047027587890625
▁were 0.7373046875
▁rec 3.419921875
ru 0.0010862350463867188
ited 6.67572021484375e-05
▁for 4.03515625
▁six 7.578125
▁months 0.482421875
▁at 3.779296875
▁two 2.515625
▁major 5.41796875
▁pain 3.19921875
▁relief 5.23828125
▁cent 1.5107421875
ers 0.0755615234375
▁in 0.72314453125
▁Israel 4.37109375
. 0.437255859375
▁The 1.1875
▁research 2.19140625
ers 1.5126953125
▁used 2.658203125
▁The 7.9296875
▁De 4.27734375
pression 0.015380859375
▁Module 9.7734375
▁of 0.966796875
▁the 0.318115234375
▁Pat 2.369140625
ient 0.0081787109375
▁Health 0.09332275390625
▁Question 0.015594482421875
naire 0.019012451171875
▁and 3.388671875
▁the 0.7109375
▁General 1.765625
ized 0.72021484375
▁An 0.017364501953125
x 0.0001386404037475586
iety 0.0030918121337890625
▁Dis 0.5478515625
order 0.03668212890625
▁Sc 1.2119140625
ale 0.06951904296875
▁to 1.732421875
▁interview 7.06640625
▁participants 2.060546875
, 3.681640625
▁evaluate 5.46875
▁their 0.75146484375
▁answers 6.52734375
, 0.93017578125
▁and 0.1531982421875
▁conduct 4.43359375
▁the 2.361328125
▁study 2.216796875
. 0.2264404296875
▁To 5.046875
▁specifically 10.0
▁evaluate 2.544921875
▁and 4.41015625
▁compare 0.978515625
▁the 0.3193359375
▁prob 11.015625
abilities 0.184814453125
▁of 0.1204833984375
▁de 0.83740234375
pression 0.0391845703125
▁or 4.66015625
▁anx 0.03765869140625
iety 0.0003485679626464844
▁among 1.69140625
▁the 2.330078125
▁diverse 8.953125
▁groups 1.61328125
, 1.572265625
▁the 0.99365234375
▁study 2.634765625
▁used 1.6259765625
▁multiple 4.765625
▁log 2.927734375
istic 0.039276123046875
▁regression 0.09625244140625
▁analysis 0.65087890625
▁and 2.521484375
▁chose 8.875
▁medical 7.48828125
▁mar 0.306640625
iju 0.0019445419311523438
ana 0.00026917457580566406
▁as 0.77001953125
▁the 1.1513671875
▁control 2.80078125
▁group 0.55859375
. 0.290283203125
<0x0A> 0.81640625
This 3.435546875
▁type 6.08203125
▁of 0.0078125
▁study 1.7431640625
▁is 1.267578125
▁the 3.3515625
▁most 1.87890625
▁reve 9.0703125
aling 0.0006647109985351562
▁and 1.060546875
▁inclus 6.53125
ive 0.00251007080078125
, 2.263671875
▁as 1.93359375
▁it 0.36865234375
▁contains 4.87890625
▁direct 6.3671875
▁responses 5.0625
▁from 0.7939453125
▁a 3.91796875
▁large 0.91357421875
▁number 0.427001953125
▁of 0.0030536651611328125
▁participants 1.47265625
. 0.65283203125
▁All 4.63671875
▁tools 9.0859375
▁in 4.5
▁the 0.6640625
▁form 3.44140625
▁of 0.045074462890625
▁question 1.7958984375
na 0.03875732421875
ires 8.940696716308594e-05
▁and 2.119140625
▁scales 3.080078125
▁have 3.591796875
▁already 4.39453125
▁been 0.1820068359375
▁used 1.923828125
▁and 2.130859375
▁proved 4.1796875
▁their 1.74609375
▁effic 4.01171875
acy 7.021427154541016e-05
▁for 3.615234375
▁collect 4.58203125
ing 0.018218994140625
▁analyt 8.09375
ical 0.22607421875
▁data 0.2783203125
. 0.42822265625
▁It 3.5625
▁helps 4.8046875
▁to 0.9443359375
▁system 7.328125
at 1.337890625
ize 0.006450653076171875
▁and 1.6162109375
▁class 4.08203125
ify 0.002071380615234375
▁distinct 9.3125
▁kinds 6.33203125
▁of 0.0251007080078125
▁information 3.474609375
▁for 3.90234375
▁subsequent 4.03125
▁un 7.99609375
comp 5.43359375
licated 0.060455322265625
▁services 11.71875
. 0.64599609375
▁Thus 4.36328125
, 0.0243988037109375
▁research 4.49609375
ers 0.5478515625
▁can 1.3994140625
▁compare 3.94140625
▁the 0.9169921875
▁effects 2.986328125
▁of 0.09893798828125
▁medic 4.3984375
ations 0.8896484375
▁on 1.7705078125
▁patients 2.1015625
▁of 4.52734375
▁diverse 4.15625
▁age 2.654296875
▁groups 0.67724609375
, 0.95263671875
▁background 5.1171875
s 0.215576171875
, 0.0728759765625
▁physical 5.3828125
▁conditions 1.4560546875
, 0.09466552734375
▁emot 5.53515625
ional 0.057220458984375
▁states 1.3857421875
, 0.1138916015625
▁and 0.443359375
▁so 3.17578125
▁on 0.326904296875
. 0.09149169921875
<0x0A> 0.6806640625
The 1.1181640625
▁analysis 4.51953125
▁of 0.55712890625
▁any 8.84375
▁hom 10.5625
o 4.7109375
▁reaction 12.765625
▁has 4.08203125
▁a 2.111328125
▁high 3.892578125
▁potential 3.541015625
▁of 1.5849609375
▁subject 6.10546875
iveness 4.29296875
▁and 1.408203125
▁bias 2.2421875
, 1.8291015625
▁especially 2.40234375
▁regarding 4.87890625
▁people 4.7421875
▁in 4.08984375
▁severe 4.65625
▁pain 0.287841796875
▁and 2.619140625
▁un 5.28125
stable 1.8916015625
▁emot 1.005859375
ional 0.1676025390625
▁condition 2.6796875
. 0.08074951171875
▁Perhaps 8.71875
▁some 5.07421875
▁patients 2.30859375
▁tend 5.44921875
▁to 0.0208282470703125
▁ex 2.7578125
agger 0.0021839141845703125
ate 0.0059661865234375
▁their 0.763671875
▁de 5.06640625
press 1.3759765625
ive 0.2366943359375
▁state 3.1171875
▁or 1.931640625
▁vice 7.21875
▁vers 0.0168914794921875
a 8.726119995117188e-05
, 1.0546875
▁de 7.421875
- 4.98046875
emph 1.119140625
as 0.00658416748046875
ize 0.1407470703125
▁serious 6.57421875
▁difficulties 5.90234375
. 0.87158203125
▁Because 6.125
▁the 2.193359375
▁survey 5.9921875
▁responses 6.7109375
▁were 1.6845703125
▁thoroughly 8.0546875
▁anonymous 5.16015625
, 0.455078125
▁the 1.4755859375
▁research 1.556640625
ers 0.303955078125
▁const 11.734375
itute 1.4033203125
▁unable 10.59375
▁to 0.01445770263671875
▁carefully 9.578125
▁analyze 1.794921875
▁each 4.1875
▁patient 2.9140625
’ 26.875
s 0.8818359375
▁reaction 3.892578125
▁and 2.3984375
▁compare 3.767578125
▁it 0.76513671875
▁to 1.2822265625
▁the 0.77294921875
▁actual 5.9375
▁states 7.40234375
▁of 0.6884765625
▁condition 7.40625
. 0.367431640625
▁More 6.64453125
▁accurate 4.03515625
▁solution 8.3046875
▁could 3.728515625
▁be 0.1270751953125
▁obtained 4.46484375
▁by 0.88330078125
▁professional 8.046875
▁psych 2.43359375
olog 0.50830078125
ists 0.0025997161865234375
▁via 7.91015625
▁personal 4.16796875
▁communication 4.41015625
▁and 1.6123046875
▁behavior 7.31640625
al 0.287109375
▁analysis 2.1640625
. 0.2384033203125
▁However 3.0625
, 0.004131317138671875
▁this 1.9970703125
▁method 2.794921875
▁of 2.50390625
▁research 2.111328125
▁is 0.8857421875
▁way 7.57421875
▁more 1.6181640625
▁resource 6.56640625
- 0.448974609375
int 0.55029296875
ensive 0.00868988037109375
▁and 0.59765625
▁energy 8.5546875
- 0.12939453125
consum 0.318603515625
ing 0.002460479736328125
. 0.5576171875
<0x0A> 0.6259765625
Part 5.69140625
icip 0.09625244140625
ants 0.11328125
▁were 1.0478515625
▁rec 1.4697265625
ru 0.001377105712890625
ited 8.630752563476562e-05
▁for 1.0234375
▁six 0.966796875
▁months 0.0196533203125
▁at 0.40380859375
▁two 0.09674072265625
▁major 0.27978515625
▁pain 0.02972412109375
▁relief 0.031951904296875
▁cent 0.026824951171875
ers 0.00579071044921875
▁in 0.05352783203125
▁Israel 0.027587890625
. 0.126220703125
▁All 3.435546875
▁affected 8.8671875
_ 13.0390625
role 8.9765625
▁experienced 8.7109375
▁chron 2.748046875
ic 0.005710601806640625
▁pain 0.08465576171875
▁for 4.26953125
▁at 0.98974609375
▁least 0.0019006729125976562
▁ 1.00390625
3 1.4853515625
▁months 0.255126953125
. 0.9892578125
▁The 1.529296875
▁study 2.12109375
▁included 2.3203125
▁ 1.1865234375
8 2.919921875
9 2.7578125
0 3.58203125
▁participants 1.3359375
, 1.3017578125
▁of 1.7197265625
▁which 0.4267578125
▁ 0.162109375
4 1.6552734375
7 2.498046875
4 2.759765625
▁( 2.123046875
5 0.11077880859375
9 11.03125
%) 1.0419921875
▁were 0.5390625
▁treated 4.5234375
▁sole 7.2734375
ly 0.00027823448181152344
▁with 0.48486328125
▁op 0.86669921875
io 0.4462890625
ids 0.2003173828125
, 1.1748046875
▁ 0.61083984375
3 1.083984375
2 2.09765625
9 2.591796875
▁( 0.052398681640625
4 1.126953125
1 1.2353515625
%) 0.12469482421875
▁were 1.3828125
▁treated 0.59228515625
▁with 0.19384765625
▁MM 0.779296875
, 0.286865234375
▁and 0.1732177734375
▁ 0.1282958984375
7 3.244140625
7 2.45703125
▁( 0.20263671875
8 3.890625
. 1.2197265625
6 2.87890625
%) 0.061981201171875
▁acquired 9.5078125
▁both 1.1611328125
▁( 7.00390625
Fe 10.0703125
ing 3.130859375
old 0.0196075439453125
▁et 1.48828125
▁al 0.028533935546875
., 0.304931640625
▁ 0.01549530029296875
2 0.1832275390625
0 0.0006585121154785156
1 0.418701171875
7 2.1015625
). 0.1507568359375
▁The 1.400390625
▁remaining 7.203125
▁ten 7.9453125
▁participants 1.2197265625
▁who 5.50390625
▁did 1.578125
▁not 0.00872802734375
▁receive 2.087890625
▁ph 3.0546875
arma 0.06732177734375
ce 0.0023860931396484375
ut 4.220008850097656e-05
ical 0.0035762786865234375
▁op 1.0166015625
io 0.0887451171875
ids 0.026275634765625
▁and 1.6123046875
▁medical 2.37109375
▁mar 0.052825927734375
iju 0.005733489990234375
ana 0.00016951560974121094
▁were 1.337890625
▁with 5.95703125
dra 0.18603515625
wn 0.00018489360809326172
▁from 0.271484375
▁the 0.11798095703125
▁analysis 4.4296875
▁in 4.796875
▁the 1.1748046875
▁research 4.25
. 0.677734375
▁Therefore 4.95703125
, 0.01137542724609375
▁it 3.728515625
▁is 0.93603515625
▁not 2.814453125
▁possible 0.66748046875
▁to 0.023956298828125
▁compreh 6.70703125
ens 0.070068359375
ively 0.01114654541015625
▁compare 2.03125
▁patients 5.09765625
▁taking 4.23046875
▁medic 3.8125
ations 0.48486328125
▁with 0.98681640625
▁those 1.1513671875
▁who 1.185546875
▁do 1.7041015625
▁not 0.01024627685546875
. 0.78076171875
<0x0A> 0.66552734375
The 1.1845703125
▁study 1.82421875
▁conducted 4.6640625
▁a 2.1328125
▁correlation 5.95703125
▁type 7.203125
▁of 0.51513671875
▁research 1.9326171875
▁with 2.837890625
▁variable 7.8984375
▁measures 4.59765625
. 1.2490234375
▁It 2.166015625
▁evaluated 4.49609375
▁the 0.556640625
▁inter 6.2890625
dep 3.37890625
end 0.0008311271667480469
ence 0.01287841796875
▁of 0.57373046875
▁various 3.935546875
▁factors 1.7197265625
▁that 2.8203125
▁affected 4.1875
▁the 0.5751953125
▁physical 6.88671875
▁and 0.9365234375
▁emot 0.44482421875
ional 0.00046944618225097656
▁condition 1.0517578125
▁of 0.115966796875
▁patients 0.7353515625
▁experien 4.04296875
cing 4.315376281738281e-05
▁chron 0.6630859375
ic 0.0007901191711425781
▁pain 0.028961181640625
. 0.2227783203125
▁For 3.826171875
▁example 1.12109375
, 0.0219573974609375
▁the 1.232421875
▁survey 5.15625
▁show 9.28125
▁that 1.6796875
▁the 1.7529296875
▁ratio 6.88671875
▁of 0.135986328125
▁female 4.515625
▁patients 1.0771484375
▁was 2.259765625
▁remark 9.515625
ably 0.0009012222290039062
▁higher 0.54248046875
▁in 2.625
▁the 1.0556640625
▁op 4.62890625
i 3.81640625
ates 0.1181640625
▁group 0.3173828125
▁compared 2.75390625
▁to 0.1295166015625
▁the 0.57421875
▁MM 0.5185546875
▁group 0.35791015625
. 0.5224609375
▁In 2.92578125
▁turn 4.07421875
, 0.006069183349609375
▁people 5.86328125
▁on 5.49609375
▁op 1.482421875
i 0.48095703125
ates 0.0038661956787109375
▁were 1.1611328125
▁more 1.0595703125
▁probably 8.0390625
▁to 0.828125
▁report 3.171875
▁major 6.08203125
▁de 0.471435546875
press 1.2294921875
ive 0.004772186279296875
▁dis 0.53564453125
orders 1.314453125
. 1.7021484375
<0x0A> 2.49609375
The 1.173828125
▁question 5.80859375
na 1.3447265625
ires 0.00013399124145507812
▁used 2.125
▁different 8.15625
▁variable 8.4375
▁measures 0.73876953125
▁to 1.3876953125
▁collect 2.337890625
▁information 1.9365234375
. 1.65234375
▁For 1.9091796875
▁example 0.2060546875
, 0.01187896728515625
▁it 3.958984375
▁included 2.6171875
▁compreh 8.46875
ensive 0.0296478271484375
▁so 6.6953125
cio 0.032501220703125
- 0.3984375
dem 0.0892333984375
ographic 0.0450439453125
▁data 1.0556640625
: 4.703125
▁gender 1.591796875
, 0.09814453125
▁age 0.2203369140625
, 0.0880126953125
▁country 4.36328125
, 1.3046875
▁type 4.33984375
▁of 0.06787109375
▁residence 3.853515625
▁( 3.51171875
urban 2.06640625
/ 2.884765625
r 0.06707763671875
ural 0.0006971359252929688
), 0.2490234375
▁years 5.97265625
▁of 0.1802978515625
▁education 0.66259765625
, 0.1568603515625
▁and 1.916015625
▁employ 3.64453125
ment 0.005023956298828125
▁status 0.457275390625
. 0.1810302734375
▁Pat 4.296875
ients 0.10308837890625
▁were 1.267578125
▁also 0.9912109375
▁asked 0.63037109375
▁about 1.1494140625
▁their 0.6552734375
▁medical 2.71484375
▁history 0.4189453125
▁over 8.7421875
▁the 0.1763916015625
▁years 3.99609375
▁and 1.859375
▁the 1.8427734375
▁current 3.361328125
▁presence 5.8359375
▁of 0.051239013671875
▁any 2.6640625
▁severe 4.50390625
▁dise 1.5556640625
ases 0.00014078617095947266
▁such 4.2109375
▁as 0.006160736083984375
▁heart 2.3359375
▁failure 2.126953125
, 0.1805419921875
▁di 1.8818359375
ab 0.0019893646240234375
etes 0.005046844482421875
, 0.1292724609375
▁ar 3.74609375
th 0.1444091796875
rit 0.0345458984375
is 0.01282501220703125
, 0.051666259765625
▁and 1.55859375
▁so 0.7236328125
▁on 0.0338134765625
. 0.051605224609375
▁The 1.9189453125
▁third 7.0625
▁measure 3.900390625
▁of 2.0859375
▁the 1.0205078125
▁question 3.056640625
naire 0.159912109375
▁was 1.0498046875
▁indicated 9.7734375
▁by 0.6982421875
▁information 6.5859375
▁on 1.6806640625
▁any 5.32421875
▁twelve 13.4609375
- 1.2509765625
month 0.369873046875
▁and 5.82421875
▁lifetime 3.26953125
▁drug 4.609375
▁and 3.31640625
▁alco 0.074462890625
hol 0.00012218952178955078
▁consumption 2.591796875
. 0.452392578125
▁In 3.453125
▁addition 0.82177734375
, 0.1207275390625
▁the 1.1787109375
▁record 7.74609375
▁included 1.7822265625
▁a 2.5625
▁pain 6.4375
▁measurement 4.34375
▁scale 1.08203125
▁from 3.654296875
▁ 0.479248046875
0 0.425537109375
▁to 0.424072265625
▁ 0.00833892822265625
1 0.08544921875
0 0.07220458984375
▁to 4.5625
▁evaluate 1.5888671875
▁dis 5.94921875
com 0.2147216796875
fort 0.002109527587890625
▁feelings 7.1875
▁during 3.287109375
▁the 0.88525390625
▁last 1.4140625
▁month 1.59375
. 0.280029296875
<0x0A> 1.1064453125
Am 6.99609375
ong 0.01812744140625
▁all 2.341796875
▁participants 1.888671875
▁in 3.541015625
▁the 0.1845703125
▁study 0.455078125
, 0.0721435546875
▁ 0.68505859375
4 1.7744140625
2 2.732421875
. 1.8896484375
2 2.294921875
% 0.1431884765625
▁suffered 4.74609375
▁from 0.1492919921875
▁de 1.869140625
pression 0.1656494140625
, 1.0634765625
▁and 1.798828125
▁ 0.150390625
3 1.7001953125
7 2.22265625
% 2.728515625
▁experienced 2.3125
▁excess 7.87109375
ive 0.09576416015625
▁anx 0.246826171875
iety 0.0018644332885742188
. 0.35302734375
▁The 1.455078125
▁pl 11.1015625
ur 1.125
ality 0.0002655982971191406
▁of 0.2005615234375
▁de 3.6015625
press 1.2880859375
ive 0.02410888671875
▁dis 1.88671875
orders 0.06939697265625
▁among 3.763671875
▁patients 1.2880859375
▁in 3.607421875
▁the 0.3916015625
▁op 1.4892578125
i 0.96533203125
ates 0.005405426025390625
, 6.9609375
▁medical 2.95703125
▁mar 0.0284881591796875
iju 0.00794219970703125
ana 6.258487701416016e-05
, 0.140625
▁and 0.07537841796875
▁mixed 6.16796875
▁OP 8.765625
MM 5.73828125
▁groups 0.495849609375
▁number 7.91796875
ed 0.0179290771484375
▁ 0.1383056640625
5 2.216796875
7 2.5
. 0.218505859375
1 2.3515625
%, 0.2437744140625
▁ 0.005382537841796875
2 3.056640625
2 2.443359375
. 0.1092529296875
3 2.234375
%, 0.119384765625
▁and 0.03631591796875
▁ 0.0033550262451171875
5 3.21484375
1 2.544921875
. 0.173583984375
4 2.15234375
%, 0.399658203125
▁respectively 0.0118560791015625
. 0.293212890625
▁The 1.5107421875
▁pl 4.53515625
ur 0.0228271484375
ality 4.208087921142578e-05
▁of 0.04290771484375
▁anx 0.9130859375
iety 0.0117340087890625
▁contained 10.9765625
▁ 0.61962890625
4 1.580078125
8 2.37890625
. 0.060943603515625
4 2.3125
% 0.54541015625
▁among 1.484375
▁OP 6.515625
▁patients 9.0
, 0.271240234375
▁ 0.09906005859375
2 1.5146484375
1 2.41796875
. 0.134033203125
5 2.431640625
% 0.01212310791015625
▁among 0.465087890625
▁MM 0.363525390625
▁patients 0.30126953125
, 0.01352691650390625
▁and 0.01476287841796875
▁ 0.03704833984375
3 1.2294921875
8 2.638671875
. 0.1585693359375
7 2.291015625
% 0.01396942138671875
▁among 0.2403564453125
▁OP 4.0546875
MM 0.2147216796875
▁participants 3.4609375
. 0.233642578125
▁Pat 5.98828125
ients 0.0240631103515625
▁who 2.4921875
▁took 2.900390625
▁strong 8.2578125
▁op 1.1982421875
i 1.4140625
ates 0.003658294677734375
▁were 1.7666015625
▁t 8.6171875
ended 1.044921875
▁to 0.0179595947265625
▁place 10.3203125
▁their 3.66796875
▁pain 2.669921875
▁on 3.369140625
▁a 0.931640625
▁scale 2.384765625
▁of 0.630859375
▁ 0.375
9 2.8046875
▁to 1.3935546875
▁ 0.017669677734375
1 0.023040771484375
0 0.09173583984375
▁( 2.517578125
Fe 1.6044921875
ing 0.009033203125
old 0.0006322860717773438
▁et 0.036529541015625
▁al 0.0013017654418945312
., 0.0083160400390625
▁ 0.002399444580078125
2 0.0006508827209472656
0 4.267692565917969e-05
1 0.002071380615234375
7 0.0144805908203125
). 0.055328369140625
▁They 4.8125
▁were 1.3486328125
▁also 1.37890625
▁an 8.7421875
gu 4.7109375
ished 0.05438232421875
▁em 8.640625
otion 0.0131683349609375
ally 0.007373809814453125
▁and 1.1572265625
▁react 6.859375
ed 0.08154296875
▁rad 9.4140625
ically 0.00469970703125
▁neg 5.3984375
atively 0.0014104843139648438
▁to 0.35986328125
▁almost 5.24609375
▁all 1.1962890625
▁survey 8.390625
▁questions 0.7021484375
. 0.29736328125
▁Pat 4.5
ients 0.00901031494140625
▁who 1.2548828125
▁took 1.5185546875
▁only 5.51953125
▁MM 0.8740234375
▁or 3.27734375
▁mixed 3.4609375
▁medic 2.728515625
ations 0.34765625
▁course 12.4609375
▁had 2.525390625
▁a 1.31640625
▁significantly 2.51953125
▁more 3.92578125
▁stable 3.7890625
▁emot 1.150390625
ional 0.01148223876953125
▁state 0.87451171875
▁and 1.4443359375
▁cop 5.4375
ed 0.8203125
▁with 0.7099609375
▁pain 1.486328125
▁more 1.671875
▁manage 6.75390625
able 2.1015625
. 0.53369140625
<0x0A> 0.69580078125
One 5.25390625
▁of 0.6064453125
▁the 0.0263214111328125
▁major 2.53125
▁restriction 10.8984375
▁is 4.49609375
▁the 0.92138671875
▁ins 5.08984375
u 0.0282745361328125
fficient 0.09912109375
ly 4.5078125
▁high 3.087890625
▁response 2.9296875
▁rate 0.2088623046875
, 2.5390625
▁ 4.37890625
5 1.9326171875
7 2.037109375
% 2.1875
▁instead 7.55078125
▁of 0.01239776611328125
▁ 0.74365234375
7 1.546875
0 1.564453125
% 1.091796875
▁( 1.7578125
Fe 0.329833984375
ing 0.0046844482421875
old 0.0006327629089355469
▁et 0.00885772705078125
▁al 0.0008306503295898438
., 0.00554656982421875
▁ 0.00201416015625
2 0.0005469322204589844
0 2.8014183044433594e-05
1 0.0011491775512695312
7 0.0079498291015625
). 0.042572021484375
▁It 2.703125
▁can 3.228515625
▁be 0.30029296875
▁fairly 8.2890625
▁explained 1.5576171875
▁by 0.2139892578125
▁the 0.36572265625
▁weak 8.015625
▁focus 7.24609375
▁of 0.44921875
▁respond 5.8203125
ents 0.12841796875
▁who 3.57421875
▁have 3.78515625
▁overcome 8.2109375
▁severe 2.265625
▁pain 0.521484375
▁sens 8.5390625
ations 1.1806640625
▁and 1.2646484375
▁de 4.1875
press 1.69921875
ive 0.2578125
▁episodes 4.09765625
. 0.59130859375
▁It 3.232421875
▁is 0.8642578125
▁not 2.615234375
▁clear 4.5078125
▁how 1.810546875
▁to 3.2890625
▁use 5.265625
▁these 3.048828125
▁statistics 3.59765625
, 2.529296875
▁as 1.443359375
▁they 1.28125
▁still 5.9921875
▁may 4.890625
▁be 1.2607421875
▁relevant 5.51953125
▁for 1.3427734375
▁the 1.841796875
▁overall 4.515625
▁analysis 3.044921875
. 1.0732421875
